Purchase Order 75N92021P00061
- Not listed
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $727,499 firm fixed price purchase order to Biocomx Biocomx Division. The order was issued under a solicitation seeking proposals for a Biomedical Medical Device Commercialization Entrepreneurial Training opportunity. Biocomx will provide virtual training to assist up to 50 entrepreneurs and small businesses over the course of one base year and one option year in...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $14,949,405.00 firm-fixed-price purchase order to Biocomx, a minority-owned, Hispanic American-owned non-profit organization. The contract is for the Biomedical Medical Device Commercialization Entrepreneurial Training program, which aligns with the National Interest Action Code for the Coronavirus COVID-19 pandemic. Biocomx provides training and support to early-stage...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order contract to Ascella Biosystems Inc., a for-profit manufacturer, on January 13, 2021. The $250,000.00 contract is for RADX-TECH - SUPPORT SERVICES NEEDED FOR WORK PACKAGE 1 and is associated with the Coronavirus COVID-19 national interest action. The contract does not have a set-aside designation and is scheduled for completion on January...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $576,000 firm fixed price purchase order to Nova Biomedical Corporation of Waltham, Massachusetts. The contract calls for COVID-19 related equipment including five BioProfile FLEX2 modules to support the agency's coronavirus response efforts. Performance will occur in Waltham through July 2020. No set aside designation or subcontractors were indicated. This...
- The National Institutes of Health National Heart Lung and Blood Institute awarded a $15 million firm fixed price purchase order to National Collegiate Inventors & Innovators Alliance, Inc., doing business as Venturewell, for the Rapid Acceleration of Diagnostics (RADX) Initiative - Phase 0. As part of the RADX Initiative to accelerate the development, testing, and implementation of novel diagnostics for COVID-19, this contract will support Venturewell's efforts to advance diagnostics through...
- This is a $11,910.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) to Bio X Cell, LLC, a for-profit limited liability company, for the provision of bulk antibodies for research purposes. The award supports the NIH's National Institute of Allergy and Infectious Diseases (NIAID), National Cancer Institute (NCI), and Clinical Center in their work on coronavirus testing, COVID-19 research, vaccine development, and studies on infectious diseases. Bio X Cell has...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to the National Collegiate Inventors & Innovators Alliance, Inc. (doing business as Venturewell), a non-profit organization based in Hadley, Massachusetts. The $2,097,064.03 firm fixed-price delivery order is for clinical evaluation services in support of the Rapid Acceleration of Diagnostics (RADx) initiative, which aims to...
- <p>The National Institutes of Health National Heart Lung and Blood Institute awarded a $25.21 million firm fixed price delivery order contract to the National Collegiate Inventors & Innovators Alliance, Inc., doing business as Venturewell, to provide RADX Innovation Funnel services for COVID-19 award management. The contract will be performed in Hadley, Massachusetts over a period of two years beginning March 20, 2023 through March 19, 2025.</p>
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $19,146.40 firm fixed-price purchase order to Global Life Sciences Solutions USA LLC for an 8-month service contract to provide Biacore 8K v2 instrumentation. The prime contractor, a subsidiary of Danaher Corporation, will deliver the requested biotechnology analytical equipment and associated services at the agency's facility in Bethesda, Maryland between...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $14,950.00 firm fixed price purchase order to Bio X Cell, LLC, a for-profit limited liability company. The contract is for the delivery of BIO X CELL AB 1000MG and has an ultimate completion date of August 7, 2017. This award supports COVID-19 research as well as research on vaccines and infectious diseases at the NIAID, and Bio X Cell has...
The National Institutes of Health National Heart Lung and Blood Institute awarded a $14.9 million firm fixed price purchase order to Biocomx, a division of Biocomx, to provide services in support of the National Institute of Biomedical Imaging and Bioengineering's COVID-19 RADx projects. Specifically, Biocomx will deliver technical assessments and project management services to assist the NIH NIBIB with its coronavirus-related research and development efforts. The place of performance is Bethesda, Maryland. The period of performance is one year, from January 28, 2021 through January 27, 2022. No subcontractors or set-aside designations were identified. The contract award will support the NIH NIBIB's ongoing work to accelerate the development and implementation of innovative diagnostic technologies for COVID-19.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Biomedical Device Commercialization Entrepreneurial Training Support (COVID) | 75N92021P00061 | Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute | Award Notice 1/1 | 2/2/21, 10:53 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Supplemental Agreement for work within scope | $0 | 11/22/21 | |
| P00002 | Exercise an Option | $3.4m | 9/23/21 | |
| P00001 | Exercise an Option | $5.4m | 5/24/21 | |
| Not listed | Not listed | $6.0m | 1/27/21 |